pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 5·1 min read
save

BioNTech to scale down manufacturing, over 1,800 jobs on the line

BioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downsizing ...

May 5, 2026·read at Endpoints ↗

May 5, 2026 12:53 PM EDT PeoplePharmaManufacturing BioN­Tech to scale down man­u­fac­tur­ing, over 1,800 jobs on the line Ayisha Sharma News Reporter BioN­Tech is mak­ing big cuts to its man­u­fac­tur­ing foot­print. The Ger­man com­pa­ny said in its first-quar­ter earn­ings re­lease that up to … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
78 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 7h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 10h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 10h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 11h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 12h agoHealth tech investors are looking at bigger betsEndpoints